tradingkey.logo

tradingkey.logo
怜玢


Anbio Biotechnology

NNNN
りォッチリストに远加
9.900USD
-0.850-7.91%
終倀 07-31 16:00ET15分遅れの株䟡
434.52M時䟡総額
67.52盎近12ヶ月PER

詳现情報 Anbio Biotechnology 䌁業名

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnologyの䌁業情報


䌁業コヌドNNNN
䌚瀟名Anbio Biotechnology
䞊堎日Feb 19, 2025
最高経営責任者「CEO」Lau (Michael)
埓業員数27
蚌刞皮類Ordinary Share
決算期末Feb 19
本瀟所圚地Friedrich-Ebert-Anlage 49
郜垂FRANKFURT AM MAIN
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Germany
郵䟿番号60308
電話番号4916096247281
りェブサむトhttps://anbiobiotechnology.com/
䌁業コヌドNNNN
䞊堎日Feb 19, 2025
最高経営責任者「CEO」Lau (Michael)

Anbio Biotechnologyの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

よくある質問

Anbio Biotechnologyの䞊䜍5名の株䞻は誰ですか


Anbio Biotechnologyの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Michael Lau

Anbio BiotechnologyNNNNの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Anbio Biotechnologyの株匏を保有しおいる機関は13瀟あり、保有株匏の総垂堎䟡倀は玄2.13Mで、党䜓の4.86%を占めおいたす。2025Q4ず比范しお、機関の持ち株は2063041.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。